TEST. FAIL. LEARN. REPEAT. Neuroinflammatory response in Alzheimer's disease (AD) results in altered morphology of microglia and astrocytes surrounding amyloid-β plaques. This image shows brain from a mouse model of AD labeled with Iba1/AIF-1 antibody #36618 (yellow) and several other relevant targets. OUR PROCESS - YOUR SUCCESS. You want to succeed-fast. You need antibodies you can count on to work. As a privately held company founded and led by active research scientists, we understand that. That's why we validate every one of our thousands of antibodies and research products in-house-and in multiple applications where indicated. If any product fails to meet our stringent standards, we keep refining it until it does. All to ensure that CST ® every time. www.cellsignal.com © 2022 Cell Signaling Technology, Inc. Cell Signaling Technology and CST are trademarks of Cell Signaling Technology, Inc. 22-BPA-03701-MAR22 antibodies will work for you-first time,http://www.cellsignal.com